Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12M Buy
593,306
+148,382
+33% +$3.3M 0.02% 730
2025
Q4
$8.53M Buy
444,924
+148,884
+50% +$3.13M 0.01% 870
2025
Q3
$7.13M Buy
296,040
+247,111
+505% +$5.77M 0.01% 932
2025
Q2
$952K Sell
48,929
-4,727
-9% -$69.9K ﹤0.01% 1645
2025
Q1
$690K Buy
53,656
+12,808
+31% +$206K ﹤0.01% 1688
2024
Q4
$704K Buy
+40,848
New +$816K ﹤0.01% 1578
2024
Q3
Sell
-300,811
Closed -$7.43M 1949
2024
Q2
$7.43M Buy
300,811
+188,290
+167% +$5.35M 0.02% 839
2024
Q1
$3.7M Buy
112,521
+14,597
+15% +$497K 0.01% 1091
2023
Q4
$3.56M Buy
+97,924
New +$3.36M 0.01% 1091
2023
Q3
Hold
0
1212
2020
Q2
Sell
-188,614
Closed -$1.71M 1651
2020
Q1
$1.71M Buy
188,614
+167,997
+815% +$3.38M 0.01% 946
2019
Q4
$438K Buy
+20,617
New +$457K ﹤0.01% 1612
2019
Q2
Sell
-39,816
Closed -$516K 1868
2019
Q1
$516K Buy
39,816
+21,562
+118% +$377K ﹤0.01% 1723
2018
Q4
$275K Buy
+18,254
New +$472K ﹤0.01% 1754

Other funds holding ADNT

Man Group's ADNT Position: Q1 2026 in Review

Man Group increased its Adient (ADNT) stake by 33% in Q1 2026, buying an estimated $3.3M and bringing the position to 593,306 shares worth $12M. The position accounts for 0.02% of the portfolio, ranked #730.

Man Group first reported a position in ADNT in Q4 2018 and has held it in 13 quarters since. 286 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

  • Man Group held 593,306 shares of Adient worth $12M as of Q1 2026.
  • Man Group bought 148,382 Adient shares in Q1 2026, an estimated $3.3M.
  • Adient made up 0.02% of Man Group's portfolio in Q1 2026, its #730 holding.
  • Man Group first reported a position in Adient in Q4 2018 and has held it in 13 quarters since.
  • 286 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.